All In Biotech

Drug Trial Radar · NCT07321678

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Jan 22, 2026

Primary completion

Aug 10, 2026

Study completion Aug 10, 2026

Sponsor

Sponsor type
Industry
First posted
Jan 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized, double-blind, placebo-controlled Phase II study is designed to evaluate the efficacy, safety, and tolerability of ASC30 oral tablets formulation in participants with Type 2 Diabetes Mellitus

Conditions

  • T2DM (Type 2 Diabetes Mellitus)

Interventions

  • ASC30 tabletsDrug

    ASC30 tablets administered orally once daily

  • PlaceboDrug

    Placebo administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in HbA1c up to 12 weeks in the treatment group compared with the placebo groupTime frame: Baseline and end of Week 12

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Ascletis Clinical Site

    Riverside, California

  • Ascletis Clinical Site

    San Jose, California

  • Ascletis Clinical Site

    Denver, Colorado

  • Ascletis Clinical Site

    Miami, Florida

  • Ascletis Clinical Site

    Miami, Florida

  • Ascletis Clinical Site

    Decatur, Georgia

  • Ascletis Clinical Site

    Springfield, Missouri

  • Ascletis Clinical Site

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.